Publication

Tapestry Networks recently engaged payers, self-insured employers, clinicians from health systems and independent gastroenterology practices, patient advocates, and industry representatives to discuss ways in which prior authorization (PA) could evolve to advance high-quality, clinically oriented care in inflammatory bowel disease (IBD) in an era of value and cost containment. Select stakeholders gathered for a December 2023 meeting to further explore how PA can be collaboratively advanced in the short and long term. This ViewPoints provides a synthesis of views that arose during participant conversations, supported by external literature when relevant, and will pave the way for additional published perspectives on these topics to be released in mid-2024.